Mega Genomics Limited (6667) Financial Statements

0 Followers

Mega Genomics Limited Financial Overview

Mega Genomics Limited's market cap is currently HK$1.61B. The company's EPS TTM is HK$-0.0011; its P/E ratio is 51.40; and it has a dividend yield of 2.38%. Mega Genomics Limited is scheduled to report earnings on August 31, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	¥ 247.15M	¥ 151.30M	¥ 145.73M	¥ 237.19M	¥ 203.22M
Gross Profit	¥ 117.36M	¥ 88.30M	¥ 81.72M	¥ 166.68M	¥ 146.24M
Operating Income	¥ 39.13M	¥ 18.53M	¥ 2.53M	¥ 106.19M	¥ 110.63M
EBITDA	¥ 49.68M	¥ 52.42M	¥ -5.42M	¥ 116.67M	¥ 125.49M
Net Income	¥ 26.32M	¥ 30.04M	¥ -17.62M	¥ 79.02M	¥ 79.10M
Balance Sheet
Cash & Short-Term Investments	¥ 435.70M	¥ 518.29M	¥ 399.83M	¥ 239.10M	¥ 208.45M
Total Assets	¥ 832.40M	¥ 796.54M	¥ 705.70M	¥ 772.18M	¥ 453.57M
Total Debt	¥ 29.37M	¥ 48.56M	¥ 10.99M	¥ 11.57M	¥ 169.76M
Net Debt	¥ -386.22M	¥ -469.73M	¥ -388.85M	¥ -227.53M	¥ -38.69M
Total Liabilities	¥ 221.46M	¥ 151.72M	¥ 87.70M	¥ 77.69M	¥ 277.18M
Stockholders' Equity	¥ 610.94M	¥ 644.83M	¥ 618.00M	¥ 694.50M	¥ 176.40M
Cash Flow
Free Cash Flow	¥ -16.68M	¥ 127.59M	¥ -12.10M	¥ 26.21M	¥ 101.79M
Operating Cash Flow	¥ -16.52M	¥ 163.68M	¥ -6.91M	¥ 30.63M	¥ 102.84M
Investing Cash Flow	¥ -16.88M	¥ -33.75M	¥ -2.56M	¥ -1.71M	¥ -31.09M
Financing Cash Flow	¥ -41.27M	¥ -12.91M	¥ 158.46M	¥ 2.62M	¥ 84.06M

Currency in CNY

Mega Genomics Limited Earnings and Revenue History

Income Statement >

Mega Genomics Limited Debt to Assets

Balance Sheet >

Mega Genomics Limited Cash Flow

Cash Flow >

Mega Genomics Limited Forecast EPS vs Actual EPS

Earnings >